WTAP promotes fibroblast-like synoviocyte pyroptosis in Rheumatoid arthritis by upregulating N6-methyladenosine modification of NLRP3
Journal of Bioenergetics and Biomembranes · 2024
DOI: 10.1007/s10863-024-10035-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bioenergetics and Biomembranes, 2024. Verfasst von Xiuchan Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Immunology, Tianjin Hospital, No 406 South Jiefang Road, Hexi District, Tianjin, 300221, China. tjyylxc@163.com. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Arthritis, Rheumatoid, Pyroptosis, Adenosine. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic condition characterized by inflammation and an abnormal immune response. N6-methyladenosine (m6A) methylation has altered nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing (NLRP) 3. This change is implicated in the regulation of cell pyroptosis and inflammation. WTAP has a crucial role in regulating NLRP3 m6A. In this work, we used a rat model of collagen-induced arthritis (CIA) to investigate the involvement of WTAP in the evolution of inflammation in RA. The purpose of silencing or overexpressing WTAP in RA-fibroblast-like synoviocytes (RA-FLSs) treated with TNF-α was to identify its impact on pyroptosis, NLRP3 inflammasome-related proteins, the secretion of pro-inflammatory cytokines and migration. Bioinformatics techniques were used to pinpoint the exact target controlled by WTAP. To assess WTAP and NLRP3's role in RA-FLSs, we used methylated RNA immunoprecipitation, LDH test, flow cytometry, RT-qPCR, Western blotting, and Transwell. Our results show that WTAP expression is upregulated in both RA rats and cell models. Cell pyroptosis, NLRP3-related pro-inflammatory cytokines, and migration were reduced in TNF-α-treated RA-FLSs when WTAP was knocked down, whereas overexpression of WTAP displayed the opposite effect in RA-FLSs. WTAP mediated m6A modification in the NLRP3 mRNA and enhanced its mRNA stability. These results suggested that WTAP promoted FLSs pyroptosis and related inflammatory response via NLRP3 and identified WTAP as a potential target for treating RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection Immunology, Tianjin Hospital, No 406 South Jiefang Road, Hexi District, Tianjin, 300221, China. tjyylxc@163.com.
- Department of Infection Immunology, Tianjin Hospital, No 406 South Jiefang Road, Hexi District, Tianjin, 300221, China.
Zitieren
APA
Liu, X., Xia, Z., Liu, L., & Ren, D. (2024). WTAP promotes fibroblast-like synoviocyte pyroptosis in Rheumatoid arthritis by upregulating N6-methyladenosine modification of NLRP3. Journal of Bioenergetics and Biomembranes. https://doi.org/10.1007/s10863-024-10035-w
Vancouver
Liu X, Xia Z, Liu L, Ren D. WTAP promotes fibroblast-like synoviocyte pyroptosis in Rheumatoid arthritis by upregulating N6-methyladenosine modification of NLRP3. Journal of Bioenergetics and Biomembranes. 2024. doi:10.1007/s10863-024-10035-w
BibTeX
@article{Liu2024,
author = {Liu, Xiuchan and Xia, Zhenjuan and Liu, Lei and Ren, Dongyun},
title = {WTAP promotes fibroblast-like synoviocyte pyroptosis in Rheumatoid arthritis by upregulating N6-methyladenosine modification of NLRP3},
journal = {Journal of Bioenergetics and Biomembranes},
year = {2024},
doi = {10.1007/s10863-024-10035-w}
}
EUVIMED